Around 7.7% of Americans have asthma, including 20.2 million adults and 4.6 million children. This study examines asthma mortality trends and disparities across U.S. demographic and geographic groups from 1999 to 2020. A retrospective analysis was conducted using the CDC WONDER database to examine asthma-related deaths in the U.S. from 1999 to 2020. Age-adjusted mortality rates (AAMRs) and crude mortality rates (CMRs) per 100,000 were calculated. Trends and annual percent changes (APCs) were assessed overall and stratified by sex, race, region, and age. From 1999 to 2020, the U.S. recorded 221 161 asthma-related deaths (AAMR: 3.07), mostly in medical facilities. Mortality declined from 1999 to 2018 (APC: −1.53%) but surged from 2018 to 2020 (APC: 28.63%). Females, NH Blacks, and NH American Indians had the highest mortality rates. Older adults (≥65) had the greatest burden, with younger groups showing notable increases post-2018. Rural areas and the West reported slightly higher rates than urban and other regions. Hawaii and the District of Columbia had the highest AAMRs, while Florida and Nevada had the lowest. Asthma-related mortality in the U.S. declined until 2018 but sharply increased from 2018 to 2020, with rises across all demographic groups, regions, and settings. Females, NH Blacks, and older adults consistently had higher mortality rates, while younger age groups showed recent alarming increases. Targeted interventions are urgently needed to address inequities and recent mortality surges.

This map shows the percent of a weighted number of respondents who answer “yes” both to both of the following questions: “Have you ever been told by a doctor, nurse, or other health professional that you have asthma?” and the question “Do you still have asthma?”As stated by the CDC in the methodology:Asthma prevalence describes the size of a state’s population with asthma as well as the overall asthma prevalence relative to other chronic conditions. The greater the prevalence of asthma, the greater the likelihood of adverse outcomes from asthma including emergency department visits, hospitalizations, and death. Compared with persons without asthma, persons with asthma have more days of activity limitation and missed school and missed work and are more likely to report comorbid depression.Who is included in this survey?Weighted number of respondents to BRFSS (or National Survey of Children’s Health) excluding “don’t know” and “refused” responses to the question “Have you ever been told you have asthma?”Data SourceCDC's 2017 500 Cities ProjectArcGIS Living Atlas of the World contains multiple years of 500 Cities CDC layers, which can be found here. For more information about the methodology, visit https://www.cdc.gov/500cities or contact 500Cities@cdc.gov.

These data map the rate of asthma among individuals 18 years of age and older at the census tract level. Provided by the CDC Population Level Analysis and Community Estimates (PLACES). For more information, please visit https://chronicdata.cdc.gov/500-Cities-Places/PLACES-Local-Data-for-Better-Health-Census-Tract-D/cwsq-ngmh.

This dataset contains counts and rates (per 10,000 residents) of asthma emergency department (ED) visits among Californians. The table “Asthma Emergency Department Visit Rates by County” contains statewide and county-level data stratified by age group (all ages, 0-17, 18+, 0-4, 5-17, 18-64, 65+) and race/ethnicity (white, black, Hispanic, Asian/Pacific Islander, American Indian/Alaskan Native). The table “Asthma Emergency Department Visit Rates by ZIP Code” contains zip-code level data stratified by age group (all ages, 0-17, 18+). The data are derived from the Department of Health Care Access and Information emergency department database. These data include emergency department visits from all licensed hospitals in California. These data are based only on primary discharge diagnosis codes. On October 1, 2015, diagnostic coding for asthma transitioned from ICD9-CM (493) to ICD10-CM (J45). Because of this change, CDPH and CDC do not recommend comparing data from 2015 (or earlier) to 2016 (or later). NOTE: Rates are calculated from the total number of asthma emergency department visits (not the unique number of individuals).

Users can download data regarding the socioeconomic, environmental and behavioral predictors of asthma control. BackgroundThe National Asthma Survey (NAS) is a joint effort between the Centers for Disease Control and Prevention (CDC) and National Center for Health Statistics (NCHS) and is sponsored by the National Center for Environmental Health (NCEH). The National Asthma Survey examines the health, socioeconomic, environmental, and behavioral predictors of asthma control. This survey explores the content of care and health care experiences of people with asthma. Health indicators include , but are not limited to: asthma attacks, asthma education, missed school/work days due to asthma, and prescription use. User FunctionalityUsers can download the survey instrument, methodology report, frequency count, and codebook as PDFs. Users can download the public-access dataset into SAS statistical software. Data Notes Persons over 18 years old or parents or guardians for children under 18 years of age who were most knowledgeable about the child’s health w ere interviewed. The National Asthma Survey was conducted between February 2003 and February 2004 among a national sample. The Four state sample survey was conducted in California, Texas, Illinois, and Alabama between March 2003 and March 2004.

2011 to present. BRFSS combined land line and cell phone prevalence data. BRFSS is a continuous, state-based surveillance system that collects information about modifiable risk factors for chronic diseases and other leading causes of death. Data will be updated annually as it becomes available. Detailed information on sampling methodology and quality assurance can be found on the BRFSS website (http://www.cdc.gov/brfss). Methodology: http://www.cdc.gov/brfss/factsheets/pdf/DBS_BRFSS_survey.pdf Glossary: https://chronicdata.cdc.gov/Behavioral-Risk-Factors/Behavioral-Risk-Factor-Surveillance-System-BRFSS-H/iuq5-y9ct

Rate: Number of deaths due to asthma per 100,000 adults age 65+

Definition: Deaths rate in which asthma is the underlying cause, CD-10 codes: J45-J46

Data Sources:

1) Centers for Disease Control and Prevention, National Center for Health Statistics. Compressed Mortality File. CDC WONDER On-line Database accessed at http://wonder.cdc.gov/cmf-icd10.html

2) Death Certificate Database, Office of Vital Statistics and Registry, New Jersey Department of Health

3) Population Estimates, State Data Center, New Jersey Department of Labor and Workforce Development

This dataset contains counts and rates (per 10,000 residents) of asthma hospitalizations among Californians statewide and by county. The data are stratified by age group (all ages, 0-17, 18+, 0-4, 5-17, 18-64, 65+) and race/ethnicity (white, black, Hispanic, Asian/Pacific Islander, American Indian/Alaskan Native). The data are derived from the Department of Health Care Access and Information Patient Discharge Data. These data include hospitalizations from all licensed hospitals in California. These data are based only on primary discharge diagnosis codes. On October 1, 2015, diagnostic coding for asthma transitioned from ICD-9-CM (493) to ICD-10-CM (J45). Because of this change, CDPH and CDC do not recommend comparing data from 2015 (or earlier) to 2016 (or later). NOTE: Rates are calculated from the total number of asthma hospitalizations (not the unique number of individuals).

Data on asthma in children younger than age 18 in the United States, by selected characteristics. Data are from Health, United States. Source: National Center for Health Statistics, National Health Interview Survey.

Users can download data sets and fact sheets regarding youth risk behaviors such as, physical activity, smoking and drug use, and sexual behaviors. Background The Youth Risk Behavior Surveillance System (YRBSS) is a national school-based survey conducted by the Centers for Disease Control and Prevention (CDC), as well as state, territorial, tribal and local surveys conducted by other agencies. YRBSS monitors the health risk behaviors and prevalence rates of obesity and asthma among youth and young adults. Information includes: tobacco, drug and alcohol use, sexual behaviors, dietary behaviors, and physical inactivity. Becaus e not every state participates, data on each individual state is not available. User Functionality Fact sheets are available by sex/ gender and racial/ ethnic group, state vs. national comparisons, and on specific behaviors that are ascertained from the more local surveys. Comprehensive results and publications are also available, and data files and the survey instruments can be downloaded into SPSS, SAS or Access. Data is available on the national, state, county and city levels. Data Notes Participants are students in grades 9-12. YRBSS sta rted in 1991, so data is available for every year since then and trend information is offered. The most recent data is from 2009,and the site does not specify when more recent data will become available. Information on the Methods and a Data User’s Manual are helpful tools in understanding the data.

Users can search this database pertaining to respiratory conditions such as asthma, pneumonia, bronchitis, and tuberculosis. BackgroundThe National Occupational Respiratory Mortality System (NORMS) is developed and maintained by National Institute of Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC). This surveillance system includes respiratory conditions such as: asthma, pneumonia, bronchitis, tuberculosis, lung cancer, and silicosis, among others. User FunctionalityUsers can generate national- or occupation-specific queries. Users can gener ate tables, charts and maps containing the summary statistics such as number of deaths, crude death rates, age-adjusted death rates, and years of potential life lost (YPLL ). Users can also download the dataset and/or data queries into Microsoft Excel. Data NotesThis website provides data history regarding revisions to the dataset. Data from additional sources (i.e., population estimates, comparative standard population, and life-table values) are also available. National mortality data is derived from the National Center for Health Statistics (NCHS) multiple cause of death records. These data are updated annually since 1968, unless otherwise indicated. Data are available on national, state, and county levels. The most recent d ata available is from 2007.

This dataset contains counts and rates (per 10,000 residents) of asthma hospitalizations among Californians statewide and by county. The data are stratified by age group (all ages, 0-17, 18+, 0-4, 5-17, 18-64, 65+) and race/ethnicity (white, black, Hispanic, Asian/Pacific Islander, American Indian/Alaskan Native). The data are derived from the Department of Health Care Access and Information Patient Discharge Data. These data include hospitalizations from all licensed hospitals in California. These data are based only on primary discharge diagnosis codes. On October 1, 2015, diagnostic coding for asthma transitioned from ICD-9-CM (493) to ICD-10-CM (J45). Because of this change, CDPH and CDC do not recommend comparing data from 2015 (or earlier) to 2016 (or later). NOTE: Rates are calculated from the total number of asthma hospitalizations (not the unique number of individuals).

Top 5 predictive search query terms for asthma and COPD models.

Ireland asthma treatment market is expected to grow at steady rate an impressive rate during the forecast period on account of rising prevalence of asthma, increase in air pollution, rise in number of product launches, increase in number of clinical trials for better clinical and therapeutics for asthma is expected to drive the growth of Ireland asthma treatment market during the forecast period. For instance, according to Center for Disease Control and Prevention (CDC), during the coronavirus pandemic, individuals suffering from moderate to severe asthma were at a greater risk of falling ill with acute respiratory disease